Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.
Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check35 days agoNo Change Detected
- Check50 days agoChange DetectedThe study has expanded to include 28 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check64 days agoChange DetectedAn erratum has been published in JAMA on March 8, 2022, regarding the EXTEND-IA TNK Part 2 Randomized Clinical Trial on the effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion before Thrombectomy in Patients with Large Vessel Occlusion Ischemic Stroke.SummaryDifference0.1%
- Check70 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.SummaryDifference0.1%
Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.